Azides
They are widely used in various research fields, including organic synthesis, materials science, and biomedical applications.
Azides exhibit unique reactivity, such as the azide-alkyne cycloaddition reaction, making them valuable for the development of novel compounds and materials.
Researchers can leverage PubCompare.ai, an AI-driven platform, to enhance the reproducibility and accuracy of their Azides research.
The platform helps locate protocols from literature, pre-prits, and patents, and provides AI-driven comparisons to identify the best protocols and products for their experiments.
This streamlines the research process and improves results, leading to more efficient and effective Azides studies.
Most cited protocols related to «Azides»
and optimizations to improve performance. Although an MPNN should
ideally be able to extract any information about
a molecule that might be relevant to predicting a given property,
two limitations may prevent this in practice. First, many property
prediction data sets are very small, i.e., on the order of only hundreds
or thousands of molecules. With so little data, MPNNs are unable to
learn to identify and extract all features of a molecule that might
be relevant to property prediction, and they are susceptible to overfitting
to artifacts in the data. Second, most MPNNs use fewer message passing
steps than the diameter of the molecular graph, i.e., T < diam(G), meaning atoms that
are a distance of greater than T bonds apart will
never receive messages about each other. This results in a molecular
representation that is fundamentally local rather than global in nature,
meaning the MPNN may struggle to predict properties that depend heavily
on global features.
In order to counter these limitations, we
introduce a variant of the D-MPNN that incorporates 200 global molecular
features that can be computed rapidly in silico using
RDKit. The neural network architecture requires that the features
are appropriately scaled to prevent features with large ranges dominating
smaller ranged features, as well as preventing issues where features
in the training set are not drawn from the same sample distribution
as features in the testing set. To prevent these issues, a large sample
of molecules was used to fit cumulative density functions (CDFs) to
all features. CDFs were used as opposed to simpler scaling algorithms
mainly because CDFs have the useful property that each value has the
same meaning: the percentage of the population observed below the
raw feature value. Min-max scaling can be easily biased with outliers,
and Z-score scaling assumes a normal distribution which is most often
not the case for chemical features, especially if they are based on
counts.
The CDFs were fit to a sample of 100k compounds from
the Novartis
internal catalog using the distributions available in the scikit-learn
package,45 a sample of which can be seen
in
do a similar normalization using publicly available databases such
as ZINC46 (link) and PubChem.47 (link) scikit-learn was used primarily due to the simplicity of
fitting and the final application. However, more complicated techniques
could be used in the future to fit to empirical CDFs, such as finding
the best fit general logistic function, which has been shown to be
successful for other biological data sets.48 (link) No review was taken to remove odd distributions. For example, azides
are hazardous and rarely used outside of a few specific reactions,
as reflected in the fr_azide distribution in
used for chemical screening against biological targets, the distribution
used here may not accurately reflect the distribution of reagents
used for chemical synthesis. For the full list of calculated features,
please refer to the
To incorporate these features, we modify the readout phase of the
D-MPNN to apply the feed-forward neural network f to the concatenation of the learned molecule feature vector h and the computed global features hf This
is a very general method of incorporating
external information and can be used with any MPNN and any computed
features or descriptors.
The BG505 SOSIP.664 construct was co-transfected with furin in HEK 293 GnTI−/− cells using 600 μg of BG505 SOSIP.664 and 150 μg of furin plasmid DNAs as described previously16 (link). Transfection supernatants were harvested after 7 days, and passed over either a 2G12 antibody- or VRC01 antibody-affinity column. After washing with phosphate-buffered saline (PBS), bound proteins were eluted with 3M MgCl2, 10 mM Tris pH 8.0. The eluate was concentrated to less than 5 ml with Centricon-70 and applied to a Superdex 200 column, equilibrated in 5 mM HEPES, pH 7.5, 150 mM NaCl, 0.02% azide. The peak corresponding to trimeric HIV-1 Env was identified, pooled, concentrated and used immediately or flash-frozen in liquid nitrogen and stored at −80° C.
Most recents protocols related to «Azides»
Example 20
Coupling of the ligand to the nanoparticle may be achieved uniquely by following an inclusion compound protocol with β-cyclodextrin (β-CD) on the particle spontaneously interacting with adamantane on the peptide or small molecule ligand to form an inclusion complex. Briefly, cyclodextrin-PEG-DSPE derivative will be synthesized via mono-6-deoxy-6-amino-β-cyclodextrin. One of the seven primary hydroxyl groups of β-cyclodextrin will be tosylated using p-toluenesulfonyl chloride. Substitution of the tosyl group by azide and subsequent reduction with triphenylphosphine will yield mono-6-deoxy-6-amino-β-cyclodextrin. Carboxyl-activated PEG-DSPE will be conjugated to mono-6-deoxy-6-amino-β-cyclodextrin to produce cyclodextrin-PEG-DSPE. Adamantane-amine will be directly conjugated through a short spacer in the solid phase peptide synthesis to the carboxyl end of the peptide to produce adamantane-peptide/ligand. The simple room temperature mixing of adamantane-amine and β-cyclodextrin bearing nanoparticle will produce peptide coupled targeted nanoparticle.
Example 32
Monobactam alkenyl aminal, alkenyl carbamate, alkenyl thiocarbamate, and alkenyl isourea linked β-lactam antibiotic cannabinoid conjugate components are synthesized as shown in the Scheme below. The starting material [410524-32-2] is reduced to the alcohol intermediate. This alcohol is then converted to the iodide using known (Tetrahedron, 73(29), 4150-4159; 2017) conditions. The iodide intermediate is converted to the primary amine using the two step azide addition/reduction protocol described above for synthesis of propenylamine cephem β-lactam antibiotic cannabinoid conjugate components. This amine is then reacted and connected to a cannabinoid by any of the aforementioned links, using the previously described chemistry and conditions associated with the non-alkenyl variant.
Example 47
Azide Polymer Synthesis for Click Conjugation to Alkyne Terminated DNA Oligo
A solution of azidohexanoic acid NHS ester (2.5 mg) in anhydrous DMF (100 μL) was added to a solution of the amine-functional polymer (9.9 mg) in anhydrous DMF (100 μL) under argon. Diisopropylethylamine (2 μL) was then added. The reaction was agitated at room temperature for 15 hours. Water was then added (0.8 mL) and the azide-modified polymer was purified over a NAP-10 column. The eluent was freeze dried overnight. Yield 9.4 mg, 95%.
Oligo Synthesis with Pendant Alkyne (Hexyne) for Click Conjugation to Azide Polymer
The 3′ propanol oligo A8885 (sequence YATTTTACCCTCTGAAGGCTCCP, where Y=hexynyl group and P=propanol group) was synthesized using 3′ spacer SynBase™ CPG 1000 column on an Applied Biosystems 394 automated DNA/RNA synthesizer. A standard 1.0 mole phosphoramidite cycle of acid-catalyzed detritylation, coupling, capping and iodine oxidation was used. The coupling time for the standards monomers was 40 s, and the coupling time for the 5′ alkyne monomer was 10 min.
The oligo was cleaved from the solid support and deprotected by exposure to concentrated aqueous ammonia for 60 min at room temperature, followed by heating in a sealed tube for 5 h at 55° C. The oligo was then purified by RP-HPLC under standard conditions. Yield 34 OD.
Solution Phase Click Conjugation: Probe Synthesis
A solution of degassed copper sulphate pentahydrate (0.063 mg) in aqueous sodium chloride (0.2 M, 2.5 μL) was added to a degassed solution of tris-benzo triazole ligand (0.5 mg) and sodium ascorbate (0.5 mg) in aqueous sodium chloride (0.2 M, 12.5 μL). Subsequently, a degassed solution of oligo A8885 (50 nmole) in aqueous sodium chloride (0.2 M, 30 μL) and a degassed solution of azide polymer (4.5 mg) in anhydrous DMF (50 μL) were added, respectively. The reaction was degassed once more with argon for 30 s prior to sealing the tube and incubating at 55° C. for 2 h. Water (0.9 mL) was then added and the modified oligo was purified over a NAP-10 column. The eluent was freeze-dried overnight. The conjugate was isolated as a distinct band using PAGE purification and characterized by mass spectrometry. Yield estimated at 10-20%.
Fluorescence Studies
The oligo-polymer conjugate was used as a probe in fluorescence studies. The probe was hybridized with the target A8090 (sequence GGAGCCTTCAGAGGGTAAAAT-Dabcyl), which was labeled with dabcyl at the 3′ end to act as a fluorescence quencher. The target and probe were hybridized, and fluorescence monitored in a Peltier-controlled variable temperature fluorimeter. The fluorescence was scanned every 5° C. over a temperature range of 30° C. to 80° C. at a rate of 2° C./min.
Polymer conjugation to nucleic acids can also be performed using methods adapted from the protocols described in Examples 14, 45 and 46.
Example 14
Eight NH2—PEGn-RGD peptides containing spacers of various PEG lengths (n=2, 4, 6, 8, 10, 12, 14, 16) will be prepared by adding the corresponding Boc-PEGn-NHS to RGD in a PBS buffer (pH=8.2), followed by Boc deprotection. Photo-ODIBO-NHS, prepared using previously reported procedures, will then be mixed with the prepared NH2—PEGn-RGD in a PBS buffer (pH=8.2) to produce photo-OIDBO-PEGn-RGD. N3-PEG4-cetuximab will be prepared using previously reported procedures. N3—PEG4-cetuximab and the eight photo-ODIBO-PEGn-RGD peptides (n=2, 4, 6, 8, 10, 12, 14, 16) will be used for in vitro screening (at 4° C. to minimize the internalization of targeting probes). As shown in
The ODIBO-PEGn-RGD containing the most potent PEG spacer will click with Tz-NOTA-N3 and then be radiolabeled with 64Cu, and the resulting Tz-(64Cu)NOTA-PEGn-RGD will be used for the in vitro avidity studies on U87MG cells. Tz-(64Cu)NOTA-RGD (without a PEG spacer) will be used as a negative control because the distance between RGD and cetuximab in the resulting heterodimer is too short to achieve avidity effect (proved in preliminary study,
Various references are cited in this document, which are hereby incorporated by reference in their entireties herein.
Example 25
Dry Pd/C (10 wt %, 300 mg) and azide compound 16 (3.33 g, 6.61 mmol) were added to pentafluorophenyl ester 23 in EtOAc. The reaction mixture was stirred under hydrogen atmosphere for 27 h, and then filtered through a plug of Celite, with washing of the filter pad with EtOAc. The combined organic portions were concentrated and purified by column chromatography with a gradient of 0-5% methanol in EtOAc to deliver compound 30 (3.90 g, 86% yield). MS ESI m/z calcd for C32H59N4O5SSi [M+H]+ 639.39, found 639.39.
Top products related to «Azides»
More about "Azides"
Azides are a versatile class of chemical compounds containing the azido group (-N3), widely used in organic synthesis, materials science, and biomedical applications.
They exhibit unique reactivity, such as the azide-alkyne cycloaddition (also known as 'click chemistry'), making them valuable for developing novel compounds and materials.
Researchers can leverage AI-driven platforms like PubCompaer.ai to enhance the reproducibility and accuracy of their azides research by locating protocols from literature, pre-prints, and patents, and comparing them to identify the best approaches for their experiments.
This streamlines the research process and improves results, leading to more efficient and effective azides studies.